Alexandra Toohey
@Baker Bros. Advisors Lp
Latest period2024 - Q3ReportedManaged Assets$9.649BTotal holdings93
Assets growth rate23.31%Assets growth rate (2-Q avg)10.74%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Baker Bros. Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.
Assets under management
The assets under management (AUM) of Baker Bros. Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 9.649B in assets, with a quarterly growth rate of 23.31% and a 2-quarter average growth rate of 10.74%. The portfolio is managed by Alexandra Toohey, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BGNEBeigene, Ltd.
| 24.6% | $2.373B 10.569M shares@ $224.51 avg price | |
INCYIncyte Corporation
| 21.06% | $2.032B 30.739M shares@ $66.1 avg price | Increased 0.01% |
ACADAcadia Pharmaceuticals Inc.
| 6.84% | $659.462M 42.878M shares@ $15.38 avg price | |
SMMTSummit Therapeutics Inc.
| 5.55% | $534.905M 24.425M shares@ $21.91 avg price | Increased 5.18% |
MDGLMadrigal Pharmaceuticals, Inc.
| 4.35% | $419.047M 1.975M shares@ $212.23 avg price | |
RVMDRevolution Medicines, Inc.
| 3.56% | $343.258M 7.569M shares@ $45.36 avg price | |
RYTMRhythm Pharmaceuticals, Inc.
| 3.48% | $335.21M 6.398M shares@ $52.4 avg price | Increased 0.01% |
INSMInsmed Incorporated
| 3.35% | $322.362M 4.416M shares@ $73.0 avg price | Increased 23.49% |
KYMRKymera Therapeutics, Inc.
| 2.95% | $283.787M 5.996M shares@ $47.34 avg price | Increased 0.01% |
BCYCBicycle Therapeutics Plc
| 2.21% | $212.721M 9.4M shares@ $22.64 avg price |